Abstract

BackgroundOleanolic acid (OA) has multiple pharmaceutical applications including anti-inflammatory activity, but low permeability of the molecule limits its widespread use.MethodsA cubic liquid crystalline nanoparticle (LCNP)-based gel was prepared as a potential topical delivery system for OA. The LCNP-based gel was optimized using rheological, drug release kinetic, and ex vivo permeation studies.ResultsThe studies showed that the OA was trapped in the interior of the LCNP with a crystal form of Pn3m space. The optimized LCNP formulation performed well using in vitro release studies for up to 12 h (85.49 ± 0.21%). Ex vivo permeation studies showed that the LCNP-based gel formulation was superior to a standard gel formulation. The r2 value from the Peppas equation indicated good linearity, but showed irregular (non-Fickian) diffusion, suggesting that drug release was controlled by multiple processes.ConclusionsIn this study, OA-loaded LCNPs were prepared by the precursor method, resulting in a well-characterized OA-LCNP gel preparation. The gel was shown to be effective in a rodent carrageenan-induced hind paw inflammation model with sustained efficacy after a single application.

Highlights

  • Many plants in nature have been proven to have a variety of pharmacological activities, prompting scientists to find ingredients with specific activities in them for better treatment of various diseases

  • The results showed that the oral bioavailability of liquid crystal nanoparticles (LCNP)-curcumin was significantly improved [26]

  • Based on our previous work and referenced evidence, in this study we explored the possibility of LCNP as a carrier system for a topical formulation of Oleanolic acid (OA)

Read more

Summary

Introduction

Many plants in nature have been proven to have a variety of pharmacological activities, prompting scientists to find ingredients with specific activities in them for better treatment of various diseases. Many triterpenoids including OA have been shown to have a wide range of pharmacological activities [1] including being an antioxidant, hypoglycemic, anti-inflammatory, antibacterial, and. Cubic liquid crystal nanoparticles (LCNP) are being investigated as a universal carrier for drug delivery [20,21,22,23,24] to improve the oral bioavailability of the drug because of high encapsulation efficiency, drug loading and bio-affinity [25]. We prepared curcumin and piperine-loaded LCNP using a precursor injection method. The results showed that the oral bioavailability of LCNP-curcumin was significantly improved [26]. Oleanolic acid (OA) has multiple pharmaceutical applications including anti-inflammatory activity, but low permeability of the molecule limits its widespread use

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call